HRT Financial’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-138,325
Closed -$5.85M 3875
2025
Q4
$5.85M Sell
138,325
-64,873
-32% -$2.65M 0.02% 702
2025
Q3
$8.55M Buy
203,198
+109,132
+116% +$5.43M 0.03% 445
2025
Q2
$5.2M Buy
94,066
+79,180
+532% +$3.95M 0.02% 523
2025
Q1
$845K Buy
+14,886
New +$930K 0.01% 1191
2024
Q3
Sell
-2,729
Closed -$368K 2492
2024
Q2
$368K Buy
+2,729
New +$417K ﹤0.01% 1428
2023
Q2
Sell
-31,280
Closed -$3.41M 2545
2023
Q1
$3.41M Buy
+31,280
New +$3.61M 0.04% 377
2022
Q4
Sell
-62,928
Closed -$5.68M 2525
2022
Q3
$5.68M Buy
62,928
+43,206
+219% +$4.75M 0.06% 256
2022
Q2
$2.32M Buy
+19,722
New +$2.83M 0.03% 509
2022
Q1
Sell
-26,710
Closed -$4.49M 3167
2021
Q4
$4.49M Buy
+26,710
New +$4.35M 0.03% 325
2021
Q2
Sell
-31,550
Closed -$4.73M 2911
2021
Q1
$4.73M Buy
31,550
+5,902
+23% +$811K 0.05% 310
2020
Q4
$3.33M Buy
+25,648
New +$3.19M 0.07% 215
2020
Q3
Sell
-13,925
Closed -$1.2M 1931
2020
Q2
$1.2M Buy
+13,925
New +$1.16M 0.04% 490
2020
Q1
Sell
-7,920
Closed -$975K 827
2019
Q4
$975K Buy
7,920
+4,275
+117% +$526K 0.04% 346
2019
Q3
$445K Sell
3,645
-8,666
-70% -$976K 0.02% 736
2019
Q2
$1.33M Buy
+12,311
New +$1.28M 0.08% 231

Other funds holding CE

HRT Financial's CE Position: Q1 2026 in Review

HRT Financial sold out of Celanese (CE) in Q1 2026, closing a stake of 138,325 shares — an estimated $5.85M sold.

HRT Financial first reported a position in CE in Q2 2019 and held it in 15 quarters. The position peaked at $8.55M in Q3 2025. 471 funds tracked by Wall St. Rank hold CE as of Q1 2026.

  • HRT Financial reported no remaining Celanese position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 138,325 Celanese shares in Q1 2026, an estimated $5.85M.
  • HRT Financial first reported a position in Celanese in Q2 2019 and held it in 15 quarters.
  • HRT Financial's Celanese position peaked at $8.55M in Q3 2025.
  • 471 funds tracked by Wall St. Rank held Celanese as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.